Nostos Genomics develops AI-driven software to accelerate and scale rare disease diagnostics. Our mission is to reduce the interpretation bottleneck in genomics by providing clinical and diagnostic laboratories with fast, transparent, and reliable variant interpretation so more patients receive timely genetic diagnoses.

We offer AION, an automated variant interpretation platform that identifies likely pathogenic variants in under 30 minutes and generates comprehensive reports and exports. AION uses a white-box approach so clinicians can verify predictions, and provides accurate decision support (validated sensitivity >93% in trios). The platform is CE‑IVDR certified and GDPR compliant, requires no complex implementation, and is designed to let labs focus on the most complex cases.